Bristol-Myers Squibb skin cancer drug wins Prix Galien USA Prize

Yervoy shortlisted for Prix Galien Prize in Germany

PRINCETON, N.J. — A cancer drug made by Bristol-Myers Squibb has received an award from Galien Foundation, the drug maker said Wednesday.

The company said Yervoy (ipilimumab) received the 2012 Prix Galien USA Prize in the Best Biotechnology Product category. Yervoy — used to treat melanoma that has spread to other parts of the body, known as metastasis — is the first new drug for melanoma that is metastatic or can't be removed through surgery in more than a decade.

The selection committee for the ceremony includes several Nobel Laureates, and the drug has been shortlisted for the Prix Galien Prize in Germany, Bristol-Myers Squibb said.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

Recommended stories

Login or Register to post a comment.